Intervention Protocol

Antiviral treatments for lamivudine-resistant chronic hepatitis B adult patients

  1. Anat Fisher*,
  2. Vijaya M Musini,
  3. Ken Bassett

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 17 JUN 2009

DOI: 10.1002/14651858.CD008178


How to Cite

Fisher A, Musini VM, Bassett K. Antiviral treatments for lamivudine-resistant chronic hepatitis B adult patients (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008178. DOI: 10.1002/14651858.CD008178.

Author Information

  1. University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, Canada

*Anat Fisher, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, V6T 1Z3, Canada. Anat.Fisher@ti.ubc.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 7 OCT 2009

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the benefits and harms of antiviral treatments in adult patients with lamivudine-resistant chronic hepatitis B.